Back
Rocket Pharmaceuticals Vs. Lixte Biotechnology Holdings Industry Stock Comparison
Sell
36
RCKT
Rocket Pharmaceuticals
Last Price:
23.45
Seasonality Move:
1.71%
Sell
46
LIXT
Lixte Biotechnology Holdings
Last Price:
3.35
Seasonality Move:
8.17%
Sell
36
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy, Sell or Hold?
- The current Rocket Pharmaceuticals [RCKT] share price is $23.68. The Score for RCKT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- RCKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Lixte Biotechnology Holdings (LIXT)
is a Sell
Is Lixte Biotechnology Holdings a Buy, Sell or Hold?
- The current Lixte Biotechnology Holdings [LIXT] share price is $3.45. The Score for LIXT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- LIXT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals's stock price today?
-
The Rocket Pharmaceuticals share price today is $23.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.
LIXT Stock Price Chart
What is Lixte Biotechnology Holdings's stock price today?
-
The Lixte Biotechnology Holdings share price today is $3.45
The current trend is moderately bullish and LIXT is experiencing buying pressure, which is a positive indicator for future bullish movement.
RCKT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.99 | Sell |
Relative Strength Index (14 RSI): | 35.38 | Sell |
Chaikin Money Flow: | -407415 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.65 - 27.31) | Sell |
Bollinger Bands (100): | (25.25 - 29.61) | Sell |
LIXT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.24 | Buy |
Relative Strength Index (14 RSI): | 60.37 | Buy |
Chaikin Money Flow: | 7257 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.42 - 3.54) | Buy |
Bollinger Bands (100): | (2 - 2.94) | Buy |
RCKT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.45 | Sell |
20-day SMA: | 25.69 | Sell |
50-day SMA: | 27.47 | Sell |
200-day SMA: | 22.96 | Buy |
8-day EMA: | 24.46 | Sell |
20-day EMA: | 25.43 | Sell |
50-day EMA: | 26.54 | Sell |
200-day EMA: | 24.28 | Sell |
LIXT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.37 | Buy |
20-day SMA: | 3.13 | Buy |
50-day SMA: | 2.72 | Buy |
200-day SMA: | 2.73 | Buy |
8-day EMA: | 3.38 | Buy |
20-day EMA: | 3.17 | Buy |
50-day EMA: | 2.83 | Buy |
200-day EMA: | 3.28 | Buy |
Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.26 per share, an increase this year of $0.38 per share, and an increase next year of $0.83 per share.
Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rocket Pharmaceuticals Technical Analysis
Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lixte Biotechnology Holdings Technical Analysis
Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |